Skip to main content

Maetzold Derek J's Form 4 filing

Castle Biosciences Inc (CSTL) · filed Nov 12, 2021

Accession no.
0001447362-21-000257
Filed
Nov 12, 2021
Trade date
Nov 9-10, 2021
Filing delay
3 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market sales total $209.2K. It was filed 3 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Maetzold Derek JCIK 0001239501Director, Officer (Pres. & Chief Exec. Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 9, 2021Common StockSSaleDisposed−433$55.40F2−$23,988.2128,528Indirect
Nov 9, 2021Common StockSSaleDisposed−133$56.67F4−$7,537.11128,395Indirect
Nov 9, 2021Common StockSSaleDisposed−67$57.54F5−$3,855.18128,328Indirect
Nov 9, 2021Common StockSSaleDisposed−200$59.09F6−$11,818128,128Indirect
Nov 9, 2021Common StockSSaleDisposed−433$55.40F2−$23,988.2151,367Indirect
Nov 9, 2021Common StockSSaleDisposed−133$56.67F4−$7,537.11151,234Indirect
Nov 9, 2021Common StockSSaleDisposed−67$57.54F5−$3,855.18151,167Indirect
Nov 9, 2021Common StockSSaleDisposed−200$59.09F6−$11,818150,967Indirect
Nov 9, 2021Common StockSSaleDisposed−434$55.40F2−$24,043.6138,765Indirect
Nov 9, 2021Common StockSSaleDisposed−134$56.67F4−$7,593.78138,631Indirect
Nov 9, 2021Common StockSSaleDisposed−66$57.54F5−$3,797.64138,565Indirect
Nov 9, 2021Common StockSSaleDisposed−200$59.09F6−$11,818138,365Indirect
Nov 10, 2021Common StockSSaleDisposed−134$55.59F9−$7,449.06127,994Indirect
Nov 10, 2021Common StockSSaleDisposed−233$56.52F10−$13,169.16127,761Indirect
Nov 10, 2021Common StockSSaleDisposed−33$57.26−$1,889.58127,728Indirect
Nov 10, 2021Common StockSSaleDisposed−133$55.59F9−$7,393.47150,834Indirect
Nov 10, 2021Common StockSSaleDisposed−234$56.52F10−$13,225.68150,600Indirect
Nov 10, 2021Common StockSSaleDisposed−33$57.26−$1,889.58150,567Indirect
Nov 10, 2021Common StockSSaleDisposed−133$55.59F9−$7,393.47138,232Indirect
Nov 10, 2021Common StockSSaleDisposed−233$56.52F10−$13,169.16137,999Indirect
Nov 10, 2021Common StockSSaleDisposed−34$57.26−$1,946.84137,965Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $55.020 to $55.880, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 3 transactions in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $56.080 to $56.970, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 3 transactions in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $57.255 to $57.860, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 3 transactions in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $58.540 to $59.375, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 3 transactions in Table I.

F9

This transaction was executed in multiple trades at prices ranging from $55.060 to $55.950, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 3 transactions in Table I.

F10

This transaction was executed in multiple trades at prices ranging from $56.180 to $57.020, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 3 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)